LBF232nnPG02: Difference between revisions
No edit summary |
No edit summary |
||
| (20 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
| Line 4: | Line 6: | ||
|LipidBank=XPR1763 | |LipidBank=XPR1763 | ||
|LipidMaps=LMFA03010081 | |LipidMaps=LMFA03010081 | ||
|SysName= 9alpha,11alpha,15S- | |SysName=(9alpha,11alpha,15S) -Trihydroxy-17-phenyl-18,19,20-trinor-prosta- (cis-5,trans-13) -dien-1-oic acid | ||
|Common Name=&&17-phenyl trinor Prostaglandin | |Common Name=&&17-phenyl trinor Prostaglandin F_2 alpha&&(9alpha,11alpha,15S) -Trihydroxy-17-phenyl-18,19,20-trinor-prosta- (5Z,13E) -dien-1-oic acid&& | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity=17-phenyl trinor Prostaglandin F2 alpha reduces the intraocular pressure in the cat eye.[[Reference:Yokotani_K:Nishihara_M:Murakami_Y:Hasegawa_T:Okuma_Y:Osumi_Y:,Br. J. Pharmacol.,1995,115,672|{{RelationTable/GetFirstAuthor|Reference:Yokotani_K:Nishihara_M:Murakami_Y:Hasegawa_T:Okuma_Y:Osumi_Y:,Br. J. Pharmacol.,1995,115,672}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | |||
Latest revision as of 09:06, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1763 |
| LipidMaps | LMFA03010081 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF232nnPG02 |
| 17-phenyl trinor Prostaglandin F2α | |
|---|---|
| |
| Structural Information | |
| (9α,11α,15S) -Trihydroxy-17-phenyl-18,19,20-trinor-prosta- (cis-5,trans-13) -dien-1-oic acid | |
| |
| Formula | C23H32O5 |
| Exact Mass | 388.224974134 |
| Average Mass | 388.49718 |
| SMILES | C(c(c2)cccc2)C[C@@H](C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@H](O)1)O)O |
| Physicochemical Information | |
| 17-phenyl trinor Prostaglandin F2 alpha reduces the intraocular pressure in the cat eye. Yokotani_K et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
